Evidence map›Paper›PMID 31173687›Full record

ArticleACS applied materials & interfaces2019

Defect Engineering of ZnO Nanoparticles for Bioimaging Applications.

Josh E Eixenberger, Catherine B Anders, Katelyn Wada, Kongara M Reddy, Raquel J Brown, Jonathan Moreno-Ramirez, Ariel E Weltner, Chinnathambi Karthik, Dmitri A Tenne, Daniel Fologea and 1 more

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Sunlight-Driven Photocatalysis in Hydrothermally Coupled ZnO/FeNanomaterials (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Green synthesis of zinc oxide nanoparticles usingRoyal Society open science · 2022
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Josh E Eixenberger
Catherine B AndersIdaho Veterans Research & Education Foundation , Boise VA Medical Center , 500 West Fort Street , Boise , Idaho 83702 , United States.
Katelyn Wada
Kongara M Reddy
Raquel J Brown
Jonathan Moreno-RamirezRiverstone International School , 5521 East Warm Springs Avenue , Boise , Idaho 83716 , United States.
Ariel E Weltner
Chinnathambi Karthik
Dmitri A Tenne

Funding

Women's health: interplay of maternal diet and key demographics on neurological health in the rural frontier and remote WestP20GM103408 · NIGMS · UNIVERSITY OF IDAHO · PI Carolyn Hovde Bohach · 2012 to 2026
$59.8M
VPS35 D620N inhibits autophagy through disrupted hyaluronic acid-CD44 signalingP20GM109095 · NIGMS · BOISE STATE UNIVERSITY · PI OXFORD, JULIA THOM · 2014 to 2023
$22.7M
Preferential cytotoxic actions of metal oxide nanoparticles against cancerR15CA141358 · NCI · BOISE STATE UNIVERSITY · PI WINGETT, DENISE G · 2010 to 2010
$212k
NCI NIH HHS R15 CA141358NIGMS NIH HHS P20 GM103408NIGMS NIH HHS P20 GM109095
6 · The paper itself

Abstract

Many promising attributes of ZnO nanoparticles (nZnO) have led to their utilization in numerous electronic devices and biomedical technologies. nZnO fabrication methods can create a variety of intrinsic defects that modulate the properties of nZnO, which can be exploited for various purposes. Here we developed a new synthesis procedure that controls certain defects in pure nZnO that are theorized to contribute to the n-type conductivity of the material. Interestingly, this procedure created defects that reduced the nanoparticle band gap to ∼3.1 eV and generated strong emissions in the violet to blue region while minimizing the defects responsible for the more commonly observed broad green emissions. Several characterization techniques including thermogravimetric analysis, Fourier-transform infrared spectroscopy, X-ray photoelectron spectroscopy, transmission electron microscopy, Raman, photoluminescence, and inductively coupled plasma mass spectrometry were employed to verify the sample purity, assess how modifications in the synthesis procedure affect the various defects states, and understand how these alterations impact the physical properties. Since the band gap significantly decreased and a relatively narrow visible emissions band was created by these defects, we investigated utilizing these new nZnO for bioimaging applications using traditional fluorescent microscopy techniques. Although most nZnO generally require UV excitation sources to produce emissions, we demonstrate that reducing the band gap allows for a 405 nm laser to sufficiently excite the nanoparticles to detect their emissions during live-cell imaging experiments using a confocal microscope. This work lays the foundation for the use of these new nZnO in various bioimaging applications and enables researchers to investigate the interactions of pure nZnO with cells through fluorescence-based imaging techniques.

Indexed as

Zinc OxideHumansJurkat CellsMicroscopy, FluorescenceNanoparticlesPhotoelectron SpectroscopySpectroscopy, Fourier Transform InfraredZinc OxidebioimagingcancerdefectsfluorescencephotoluminescenceRamantoxicityZnO nanoparticles

Identifiers

PMID31173687
PMCPMC7010230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.